A Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of IONIS-ENaCRx in Healthy Volunteers and Patients With Cystic Fibrosis

NCT03647228 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Cystic Fibrosis

Interventions

DRUG: IONIS-ENaCRx
DRUG: Placebo

Sponsor

Ionis Pharmaceuticals, Inc.